Funding Opportunities

• Postbaccalaureate Research Education Program (PREP) (R25)
  (PAR-17-051)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 24, 2017; January 24, 2018; January 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)
  (PAR-17-052)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25)
  (PAR-17-053)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 27, 2017; January 26, 2018; and January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
  (RFA-CA-17-010)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2017; May 26, 2017; September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
  (RFA-CA-17-011)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2017; May 26, 2017; September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)
  (RFA-CA-17-012)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2017; May 26, 2017; September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
  (RFA-CA-17-013)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2017; May 26, 2017; September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Coordinating Unit for the Mouse Metabolic Phenotyping Centers (U24)
  (RFA-DK-16-034)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): January 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Coordinating Unit for Diabetic Complications Consortium (U24)
  (RFA-DK-16-036)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): January 12, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NICHD Genomic Clinical Variant Expert Curation Panels (U24)
  (RFA-HD-17-001)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): January 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Knowledge Management Center for Illuminating the Druggable Genome (U24)
  (RFA-RM-16-024)
  NIH Roadmap Initiatives
  Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24)
  (RFA-RM-16-025)
  NIH Roadmap Initiatives
  Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Data and Resource Generation Centers for Illuminating the Druggable Genome (U24)
  (RFA-RM-16-026)
  NIH Roadmap Initiatives
  Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.